Mark Stanley Berger insider trades

Open-market stock purchases and sales by Mark Stanley Berger, Chief Medical Officer at Genprex, Inc, from SEC Form 4 filings since Jun 15, 2017.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +24%.

Recent trades

DateStockTradeValue
Feb 27, 2026GNPX Genprex, IncSold (not open market)$14.3K
Dec 22, 2025GNPX Genprex, IncBought (not open market)—

Companies traded

  • GNPX Genprex, Inc: other filings, last Feb 27, 2026
  • ATNM Actinium Pharmaceuticals, Inc: 1 buy, last Sep 1, 2021

Get free alerts when Mark Stanley Berger files a new trade →